Background: Multimorbidity is increasing among adults in the United States. Yet limited research has examined multimorbidity clusters in persons aged 50 years and older with and without a history of cancer. An increased understanding of multimorbidity clusters may improve the cancer survivorship experience for survivors with multimorbidity.
Methods: We identified 7580 adults aged 50 years and older with 2 or more diseases-including 811 adults with a history of primary breast, colorectal, cervical, prostate, or lung cancer-from the 2018 National Health Interview Survey. Exploratory factor analysis identified clusters of multimorbidity among cancer survivors and individuals without a history of cancer (controls). Frequency tables and chi-square tests were performed to determine overall differences in sociodemographic characteristics, health-related characteristics, and multimorbidity between groups.
Results: Cancer survivors reported a higher prevalence of having 4 or more diseases compared to controls (57% and 38%, respectively). Our analysis identified 6 clusters for cancer survivors and 4 clusters for controls. Three clusters (pulmonary, cardiac, and liver) included the same diseases for cancer survivors and controls.
Conclusions: Diseases clustered differently across adults ≥ 50 years of age with and without a history of cancer. Findings from this study may be used to inform clinical care, increase the development and dissemination of multilevel public health interventions, escalate system improvements, and initiate innovative policy reform.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10785430 | PMC |
http://dx.doi.org/10.1186/s12877-023-04603-9 | DOI Listing |
Eur Arch Otorhinolaryngol
December 2024
Department of Otorhinolaryngology, Osakidetza, Donostia University Hospital, Biodonostia Research Institute, Donostia - San Sebastian, 20014, Spain.
Purpose: Head and neck cancer (HNC) remains a significant global health concern with rising incidence and substantial impacts on patients' quality of life. Patients often experience adverse effects from both the disease and its treatment, affecting daily functions and social interactions. This study assesses the usability, interest, and satisfaction of HNC patients in using Step Oncology platform for improved treatment adherence and quality of life.
View Article and Find Full Text PDFJMIR Cancer
December 2024
Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Lübeck, Germany.
Background: Many childhood cancer survivors (CCS) develop treatment-related late effects, including an increased risk of obesity and metabolic syndrome. A healthy lifestyle can reduce the risk of associated comorbidities. Therefore, at-risk CCS could benefit from lifestyle counseling during regular long-term follow-up (LTFU).
View Article and Find Full Text PDFAnn Ital Chir
December 2024
Department of Gastrointestinal Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, 830000 Urumqi, Xinjiang, China.
J Family Med Prim Care
November 2024
Department of Pulmonary Medicine, RajaRajeswari Medical College and Hospital, Bengaluru, Karnataka, India.
J Family Med Prim Care
November 2024
Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
Background: About a third of the world's population is estimated to suffer from anaemia, and iron deficiency is expected to account for about half of all anaemia cases. This study was designed to get an estimate of the proportion of patients with iron deficiency anaemia (IDA) who have a significant gastrointestinal (GI) pathology, in particular a GI malignancy, and to identify any risk factors or predictors for the same.
Methods: This cross-sectional study was conducted at a hospital in Eastern India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!